News

A federal judge in Texas on Tuesday rejected Elevance Health’s challenge of the U.S. government's calculation for the health ...
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...
Elevance Health has lost its legal battle against the federal government over the way quality ratings are calculated for its ...
A federal judge in Texas struck down Elevance Health’s lawsuit that argued the government unfairly lowered its Medicare ...
A federal judge in Texas ruled against Elevance Health's challenge of the U.S. government's Medicare star ratings for some of ...
Elevance Health, Inc. ELV is taking a bold step in the delivery of primary care by integrating Food as Medicine into its care ...
Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of ...
Elevance Health is integrating its food as medicine program for Medicaid members in community health centers, the insurer ...
Elevance’s membership grew by 1.3 million, or 2.9%, to 48.1 million as of March 31, 2023 compared to a year ago. The growth was “driven primarily by growth in Medicaid, commercial fee-based ...
The stock's fall snapped a two-day winning streak.
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $570.0 for Elevance Health during the past quarter.
Elevance is a high quality compounder trading at a remarkably large discount to its best peer. Even the woeful Humana trades at 14.5x forward earnings, and that is before the hits to bonuses in 2026!